- recruitingPHASE2
A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
This study looks at new treatments for HIV called ‘broadly neutralising antibodies’ (bNAbs). It aims to see if two specific bNAbs can help control HIV without daily medication in people who started treatment shortly after getting HIV.
Denmark · United Kingdom - recruitingPHASE2
Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control
This study looks at new antibody treatments for people recently diagnosed with HIV. It compares standard HIV medication alone to standard medication plus special antibodies to see if the antibodies help control the virus better when treatment is paused later on.
France